drugset
drugset / Trial / NCT05632224

Postoperative Nausea and Vomiting in Laparoscopic Abdominal Surgery

NCT05632224 ↗

Phase 4 Unknown 60 enrolled Baskent University
RandomizedParallel-groupOpen-labelPrevention

Summary

The goal of this clinical trial is to compare frequency with postoperative nausea and vomiting in ASA( American Society of Anesthesiologists) I, II patients undergoing laparoscopic surgery. The main question\[s\] it aims to answer are: * Primary Outcome is the incidence of nausea and vomiting between 0-6 and 6-24 hours postoperatively and the need for additional antiemetics * Secondary outcome is detection of additional analgesic needs and complications between 0-6 and 6-24 hours postoperatively. Participants will receive aprepitant or granisetron for prevention of postoperative nausea and vomiting.

Timeline

Start
2022-11-24
Primary completion
2023-01-31
Completion
2023-01-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aprepitant Other / unclassified — —
Comparator Granisetron Other / unclassified — —

Indications

No indication recorded.